Pixelgen's funding and board moves are the focus, previewing an article about a life‑science startup accelerating commercialization and global growth.
Key Takeaways
- Pixelgen closed a $15.5 million oversubscribed Series B funding round
- Flat Capital, Navigare, and Industrifonden are listed as investors supporting expansion
- Two new board members joined: Rickard El Tarzi and Ramon Felciano, Ph.D